Pacific Biosciences Of California Total Assets 2010-2024 | PACB

Pacific Biosciences Of California total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Pacific Biosciences Of California Annual Total Assets
(Millions of US $)
2023 $1,746
2022 $1,767
2021 $2,007
2020 $414
2019 $148
2018 $170
2017 $144
2016 $138
2015 $131
2014 $124
2013 $136
2012 $130
2011 $218
2010 $306
2009 $101
Pacific Biosciences Of California Quarterly Total Assets
(Millions of US $)
2024-06-30 $1,509
2024-03-31 $1,670
2023-12-31 $1,746
2023-09-30 $1,898
2023-06-30 $1,848
2023-03-31 $1,896
2022-12-31 $1,767
2022-09-30 $1,819
2022-06-30 $1,876
2022-03-31 $1,937
2021-12-31 $2,007
2021-09-30 $2,034
2021-06-30 $1,246
2021-03-31 $1,253
2020-12-31 $414
2020-09-30 $300
2020-06-30 $214
2020-03-31 $235
2019-12-31 $148
2019-09-30 $146
2019-06-30 $171
2019-03-31 $186
2018-12-31 $170
2018-09-30 $183
2018-06-30 $137
2018-03-31 $157
2017-12-31 $144
2017-09-30 $158
2017-06-30 $178
2017-03-31 $136
2016-12-31 $138
2016-09-30 $151
2016-06-30 $161
2016-03-31 $140
2015-12-31 $131
2015-09-30 $100
2015-06-30 $97
2015-03-31 $106
2014-12-31 $124
2014-09-30 $122
2014-06-30 $128
2014-03-31 $141
2013-12-31 $136
2013-09-30 $153
2013-06-30 $134
2013-03-31 $140
2012-12-31 $130
2012-09-30 $148
2012-06-30 $170
2012-03-31 $195
2011-12-31 $218
2011-09-30 $238
2011-06-30 $261
2011-03-31 $279
2010-12-31 $306
2010-09-30 $130
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.684B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.467B 25.92
Intuitive Surgical (ISRG) United States $180.733B 94.49
Alcon (ALC) Switzerland $45.462B 32.00
Edwards Lifesciences (EW) United States $40.042B 24.90
IQVIA Holdings (IQV) United States $38.149B 21.02
IDEXX Laboratories (IDXX) United States $33.943B 39.97
DexCom (DXCM) United States $27.225B 41.00
Waters (WAT) United States $22.999B 34.01
STERIS (STE) Ireland $22.270B 25.99
SONOVA HOLDING (SONVY) Switzerland $21.961B 0.00
Hologic (HOLX) United States $19.446B 20.52
Fresenius Medical Care AG KGaA (FMS) Germany $11.766B 13.19
Sysmex ADR (SSMXY) Japan $11.599B 36.37
Globus Medical (GMED) United States $10.118B 28.30
Teleflex (TFX) United States $9.629B 15.36
Penumbra (PEN) United States $8.808B 86.28
Masimo (MASI) United States $7.841B 41.99
Glaukos (GKOS) United States $7.219B 0.00
PROCEPT BioRobotics (PRCT) United States $5.065B 0.00
Integer Holdings (ITGR) United States $4.244B 24.06
Inari Medical (NARI) United States $2.865B 0.00
TransMedics (TMDX) United States $2.852B 90.39
Veracyte (VCYT) United States $2.687B 166.57
LivaNova (LIVN) United Kingdom $2.661B 15.36
Nihon Kohden (NHNKY) Japan $2.561B 15.94
Elekta AB (EKTAY) Sweden $2.323B 18.92
Tandem Diabetes Care (TNDM) United States $2.151B 0.00
RxSight (RXST) United States $1.896B 0.00
Integra LifeSciences Holdings (IART) United States $1.871B 9.73
Alphatec Holdings (ATEC) United States $1.185B 0.00
Artivion (AORT) United States $1.150B 105.61
OPKO Health (OPK) United States $1.032B 0.00
Pulse Biosciences (PLSE) United States $0.934B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.883B 15.01
OrthoPediatrics (KIDS) United States $0.696B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.662B 0.00
Mesa Laboratories (MLAB) United States $0.641B 16.18
IRadimed (IRMD) United States $0.626B 33.81
AxoGen (AXGN) United States $0.622B 0.00
SiBone (SIBN) United States $0.568B 0.00
Paragon 28 (FNA) United States $0.506B 0.00
CVRx (CVRX) United States $0.365B 0.00
Tactile Systems Technology (TCMD) United States $0.359B 19.62
ClearPoint Neuro (CLPT) United States $0.352B 0.00
Treace Medical Concepts (TMCI) United States $0.338B 0.00
Delcath Systems (DCTH) United States $0.299B 0.00
AngioDynamics (ANGO) United States $0.274B 0.00
Sight Sciences (SGHT) United States $0.234B 0.00
Inogen (INGN) United States $0.214B 0.00
Semler Scientific (SMLR) United States $0.210B 14.62
Nevro (NVRO) United States $0.199B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Accuray (ARAY) United States $0.180B 0.00
Atossa Genetics (ATOS) United States $0.177B 0.00
Alpha Tau Medical (DRTS) Israel $0.156B 0.00
KORU Medical Systems (KRMD) United States $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.122B 0.00
908 Devices (MASS) United States $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.104B 15.51
EDAP TMS S.A (EDAP) France $0.100B 0.00
WORK Medical Technology Group (WOK) China $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.080B 0.00
Hyperfine (HYPR) United States $0.070B 0.00
LENSAR (LNSR) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
InspireMD (NSPR) Israel $0.062B 0.00
Lucid Diagnostics (LUCD) United States $0.051B 0.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.044B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Precision Optics (POCI) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.025B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
NexGel (NXGL) United States $0.019B 0.00
Baird Medical Investment Holdings (BDMD) $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
T2 Biosystems (TTOO) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Pixie Dust Technologies (PXDT) Japan $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00